Taizhou Volsen Chemical Co., Ltd.
HomeProductsActive Pharmaceutical IngredientsTrilostane For Cushing's Syndrome Treatment 13647-35-3

Trilostane For Cushing's Syndrome Treatment 13647-35-3

Payment Type:
L/C,T/T,D/P,D/A
Min. Order:
1 Gram
Transportation:
Ocean,Air
Share:
Chat Now
  • Product Description
Overview
Product Attributes

Model No.13647-35-3

BrandVOLSENCHEM

Supply Ability & Additional Information

ProductivityCustomized

TransportationOcean,Air

Place of OriginCHINA

Supply AbilityCOMMERCIAL

Payment TypeL/C,T/T,D/P,D/A

Trilostane cas number 13647-35-3 is a new action mechanism of anti-estrogen new drugs, can reduce all endogenous steroids, including estrogen and androgen formation, since it was approved in the market,scholars have studied it for postmenopausal women late Breast cancer, and published a small report of the effective report. Then,after the expiration of the patent, BioEnvision company decided to further study trilostane. A series of clinical trials were conducted in postmenopausal women who were...

Product Categories : Active Pharmaceutical Ingredients

Email to this supplier
  • *Subject:
  • *To:
    Ms. Amy Cheng
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
HomeProductsActive Pharmaceutical IngredientsTrilostane For Cushing's Syndrome Treatment 13647-35-3
Send Inquiry
*
*

Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send